Table 3.
Randomized group | mRS 0 | mRS 1 | mRS 2 | mRS 3 | mRS 4 | mRS 5–6 |
---|---|---|---|---|---|---|
Solitaire plus IV tPA | 19·7% | 18·2% | 18·3% | 9·4% | 12·5% | 21·9% |
IV tPA alone | 11·0% | 21·6% | 8·1% | 15·7% | 14·4% | 29·2% |
IV, intravenous; mRS, modified Rankin Scale; tPA, tissue plasminogen activator.